Concepedia

Noriaki Kato

NK

Statistics

Publications

13

Citations

485

H-Index

13

Active since

1965

Affiliations

Riso Kagaku (Japan)(Current)

Hirosaki University

Shinshu University

Central Research Laboratories (United Kingdom)

Noriaki Kato is an author at Riso Kagaku (Japan) specializing in medicine, pharmacology, and diabetes mellitus.

ORCID

Publications per year

1965–2018

13

Publications

13

Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats

Noriaki Kato, Kuniharu Mizuno, Mitsuhiro Makino et al. · Diabetes Research and Clinical Practice · 2000 · 59 citations

, , +9

Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes

Shinjiro Amano, Sho‐ichi Yamagishi, Noriaki Kato et al. · Biochemical and Biophysical Research Communications · 2002 · 56 citations

, , +9

Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats

Noriaki Kato, Satomi Yashima, Takeshi Suzuki et al. · Journal of Diabetes and its Complications · 2003 · 56 citations

, , +12

Amelioration of Acute Kidney Injury in Lipopolysaccharide-Induced Systemic Inflammatory Response Syndrome by an Aldose Reductase Inhibitor, Fidarestat

Kazunori Takahashi, Hiroki Mizukami, Kosuke Kamata et al. · PLoS ONE · 2012 · 53 citations · Full text

, , +17

Neurotrophin‐3‐induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose: involvement of the polyol pathway

Takeshi Suzuki, Hiromi Sekido, Noriaki Kato et al. · Journal of Neurochemistry · 2004 · 51 citations

, , +15

1–5 of 13